Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005822
Filing Date
2014-11-14
Accepted
2014-11-14 16:38:41
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mslp-10q_20140930.htm 10-Q 2524213
2 EX-31.1 mslp-ex311_201409306.htm EX-31.1 15913
3 EX-31.2 mslp-ex312_201409307.htm EX-31.2 16049
4 EX-32.1 mslp-ex321_201409308.htm EX-32.1 6527
5 EX-32.2 mslp-ex322_201409309.htm EX-32.2 6359
  Complete submission text file 0001564590-14-005822.txt   13822973

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20140930.xml EX-101.INS 2392246
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20140930.xsd EX-101.SCH 80336
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20140930_cal.xml EX-101.CAL 96381
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20140930_def.xml EX-101.DEF 242713
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20140930_lab.xml EX-101.LAB 566087
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20140930_pre.xml EX-101.PRE 443789
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

EIN.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53166 | Film No.: 141224885
SIC: 2834 Pharmaceutical Preparations